May 2025

Multidistrict litigation (MDL) in Paragraph IV patent cases presents unique strategic opportunities and challenges for both brand-name pharmaceutical companies and […]

To establish a robust Generic Drug Quality Management System (QMS), pharmaceutical manufacturers must integrate advanced methodologies, regulatory compliance, and continuous

The pharmaceutical industry is experiencing a promising turnaround in R&D returns after years of declining ROI. According to Deloitte’s 15th

The global pharmaceutical industry in 2026 exists in a state of hyper-dynamic transition, defined by the convergence of the most

Introduction: Beyond the Sticker Price – Redefining Cost in Pharmaceutical Procurement In the high-stakes world of pharmaceuticals, where innovation is

Switzerland’s pharmaceutical industry thrives on a unique interplay of regulatory excellence, innovation ecosystems, and strategic global positioning, while grappling with

We’re excited to announce that DrugPatentWatch is now available on the Snowflake Marketplace, making it easier than ever for organizations

The pharmaceutical procurement landscape is evolving rapidly, moving beyond traditional cost-focused approaches toward sophisticated value-based models that consider multiple factors

Navigating the Intersection of IPR and Hatch-Waxman Litigation: Strategic Coordination for Patent ChallengesBalancing inter partes review (IPR) proceedings with Hatch-Waxman